» Articles » PMID: 38963496

Maturation and Assembly of MTOR Complexes by the HSP90-R2TP-TTT Chaperone System: Molecular Insights and Mechanisms

Overview
Journal Subcell Biochem
Publisher Springer
Specialty Biochemistry
Date 2024 Jul 4
PMID 38963496
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanistic target of rapamycin (mTOR) is a master regulator of cell growth and metabolism, integrating environmental signals to regulate anabolic and catabolic processes, regulating lipid synthesis, growth factor-induced cell proliferation, cell survival, and migration. These activities are performed as part of two distinct complexes, mTORC1 and mTORC2, each with specific roles. mTORC1 and mTORC2 are elaborated dimeric structures formed by the interaction of mTOR with specific partners. mTOR functions only as part of these large complexes, but their assembly and activation require a dedicated and sophisticated chaperone system. mTOR folding and assembly are temporarily separated with the TELO2-TTI1-TTI2 (TTT) complex assisting the cotranslational folding of mTOR into a native conformation. Matured mTOR is then transferred to the R2TP complex for assembly of active mTORC1 and mTORC2 complexes. R2TP works in concert with the HSP90 chaperone to promote the incorporation of additional subunits to mTOR and dimerization. This review summarizes our current knowledge on how the HSP90-R2TP-TTT chaperone system facilitates the maturation and assembly of active mTORC1 and mTORC2 complexes, discussing interactions, structures, and mechanisms.

References
1.
Amit M, Weisberg S, Nadler-Holly M, McCormack E, Feldmesser E, Kaganovich D . Equivalent mutations in the eight subunits of the chaperonin CCT produce dramatically different cellular and gene expression phenotypes. J Mol Biol. 2010; 401(3):532-43. DOI: 10.1016/j.jmb.2010.06.037. View

2.
Assimon V, Tang Y, Vargas J, Lee G, Wu Z, Lou K . CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity. ACS Chem Biol. 2019; 14(2):236-244. DOI: 10.1021/acschembio.8b00904. View

3.
Ayala R, Willhoft O, Aramayo R, Wilkinson M, McCormack E, Ocloo L . Structure and regulation of the human INO80-nucleosome complex. Nature. 2018; 556(7701):391-395. PMC: 5937682. DOI: 10.1038/s41586-018-0021-6. View

4.
Aylett C, Sauer E, Imseng S, Boehringer D, Hall M, Ban N . Architecture of human mTOR complex 1. Science. 2015; 351(6268):48-52. DOI: 10.1126/science.aaa3870. View

5.
Boulon S, Marmier-Gourrier N, Pradet-Balade B, Wurth L, Verheggen C, Jady B . The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery. J Cell Biol. 2008; 180(3):579-95. PMC: 2234240. DOI: 10.1083/jcb.200708110. View